Evaluation of the Bioavailability of Pramlintide

Clinical trial NCT00042471 · COMPLETED

Trial details

NCT number: NCT00042471
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Start date: 2002-06-01
Primary completion: 2002-12-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.